Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Daiichi Sankyo
QuintilesIMS
Harvard Business School
Fish and Richardson
Covington
Baxter
Chubb
Federal Trade Commission

Generated: November 13, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017106

« Back to Dashboard

NDA 017106 describes ATROPEN, which is a drug marketed by Meridian Medcl Techn and is included in one NDA. It is available from one supplier. Additional details are available on the ATROPEN profile page.

The generic ingredient in ATROPEN is atropine sulfate. There are twenty-three drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the atropine sulfate profile page.
Summary for 017106
Tradename:ATROPEN
Applicant:Meridian Medcl Techn
Ingredient:atropine sulfate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 017106
Suppliers and Packaging for NDA: 017106
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ATROPEN atropine sulfate SOLUTION;INTRAMUSCULAR 017106 NDA Meridian Medical Technologies, Inc. 11704-104 11704-104-01 .7 mL in 1 SYRINGE, GLASS (11704-104-01)
ATROPEN atropine sulfate SOLUTION;INTRAMUSCULAR 017106 NDA Meridian Medical Technologies, Inc. 11704-105 11704-105-01 .7 mL in 1 SYRINGE, GLASS (11704-105-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAMUSCULARStrength2MG/0.7ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAMUSCULARStrength1MG/0.7ML
Approval Date:Jun 19, 2003TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAMUSCULARStrength0.5MG/0.7ML
Approval Date:Jun 19, 2003TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Chinese Patent Office
Healthtrust
Queensland Health
Covington
AstraZeneca
Julphar
Argus Health
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.